530 related articles for article (PubMed ID: 33001409)
21. Characteristics of SARS-CoV-2 positive cases beyond health-care professionals or social and health-care facilities.
Deiana G; Azara A; Dettori M; Delogu F; Vargiu G; Gessa I; Arghittu A; Tidore M; Steri G; Castiglia P
BMC Public Health; 2021 Jan; 21(1):83. PubMed ID: 33413218
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature.
Bajgain KT; Badal S; Bajgain BB; Santana MJ
Am J Infect Control; 2021 Feb; 49(2):238-246. PubMed ID: 32659414
[TBL] [Abstract][Full Text] [Related]
23. COVID-19 mortality in cirrhosis is determined by cirrhosis-associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry.
Brozat JF; Hanses F; Haelberger M; Stecher M; Dreher M; Tometten L; Ruethrich MM; Vehreschild JJ; Trautwein C; Borgmann S; Vehreschild MJGT; Jakob CEM; Stallmach A; Wille K; Hellwig K; Isberner N; Reuken PA; Geisler F; Nattermann J; Bruns T;
United European Gastroenterol J; 2022 May; 10(4):409-424. PubMed ID: 35482663
[TBL] [Abstract][Full Text] [Related]
24. Analysis of clinical characteristics and outcomes in patients with COVID-19 based on a series of 1000 patients treated in Spanish emergency departments.
Gil-Rodrigo A; Miró Ò; Piñera P; Burillo-Putze G; Jiménez S; Martín A; Martín-Sánchez FJ; Jacob J; Guardiola JM; García-Lamberechts EJ; Espinosa B; Martín Mojarro E; González Tejera M; Serrano L; Agüera C; Soy E; Llauger L; Juan MÁ; Palau A; Del Arco C; Rodríguez Miranda B; Maza Vera MT; Martín Quirós A; Tejada de Los Santos L; Ruiz de Lobera N; Iglesias Vela M; Torres Garate R; Alquézar-Arbé A; González Del Castillo J; Llorens P;
Emergencias; 2020 Ago; 32(4):233-241. PubMed ID: 32692000
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and impact of comorbidities on disease prognosis among patients with COVID-19 in Bangladesh: A nationwide study amid the second wave.
Sharif N; Opu RR; Ahmed SN; Sarkar MK; Jaheen R; Daullah MU; Khan S; Mubin M; Rahman H; Islam F; Haque N; Islam S; Khan FB; Haque N; Ayman U; Shohael AM; Dey SK; Talukder AA
Diabetes Metab Syndr; 2021; 15(4):102148. PubMed ID: 34186349
[TBL] [Abstract][Full Text] [Related]
26. Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.
Ge E; Li Y; Wu S; Candido E; Wei X
PLoS One; 2021; 16(10):e0258154. PubMed ID: 34610047
[TBL] [Abstract][Full Text] [Related]
27. Long-term infection of SARS-CoV-2 changed the body's immune status.
Lin L; Luo S; Qin R; Yang M; Wang X; Yang Q; Zhang Y; Wang Q; Zhu R; Fan H; Wang H; Hu Y; Wang L; Hu D
Clin Immunol; 2020 Sep; 218():108524. PubMed ID: 32659373
[TBL] [Abstract][Full Text] [Related]
28. Characteristics and outcomes of COVID-19 in hospitalized patients with and without diabetes.
Al-Salameh A; Lanoix JP; Bennis Y; Andrejak C; Brochot E; Deschasse G; Dupont H; Goeb V; Jaureguy M; Lion S; Maizel J; Moyet J; Vaysse B; Desailloud R; Ganry O; Schmit JL; Lalau JD
Diabetes Metab Res Rev; 2021 Mar; 37(3):e3388. PubMed ID: 32683744
[TBL] [Abstract][Full Text] [Related]
29. Cardiovascular comorbidities as predictors for severe COVID-19 infection or death.
Phelps M; Christensen DM; Gerds T; Fosbøl E; Torp-Pedersen C; Schou M; Køber L; Kragholm K; Andersson C; Biering-Sørensen T; Christensen HC; Andersen MP; Gislason G
Eur Heart J Qual Care Clin Outcomes; 2021 Mar; 7(2):172-180. PubMed ID: 33107909
[TBL] [Abstract][Full Text] [Related]
30. Decreased T cell populations contribute to the increased severity of COVID-19.
Liu R; Wang Y; Li J; Han H; Xia Z; Liu F; Wu K; Yang L; Liu X; Zhu C
Clin Chim Acta; 2020 Sep; 508():110-114. PubMed ID: 32405080
[TBL] [Abstract][Full Text] [Related]
31. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.
Adams ML; Katz DL; Grandpre J
Emerg Infect Dis; 2020 Aug; 26(8):1831-1833. PubMed ID: 32324118
[TBL] [Abstract][Full Text] [Related]
32. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
33. Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
Ioannou GN; Ferguson JM; O'Hare AM; Bohnert ASB; Backus LI; Boyko EJ; Osborne TF; Maciejewski ML; Bowling CB; Hynes DM; Iwashyna TJ; Saysana M; Green P; Berry K
PLoS Med; 2021 Oct; 18(10):e1003807. PubMed ID: 34673772
[TBL] [Abstract][Full Text] [Related]
34. The outcomes of patients with diabetes mellitus in The Philippine CORONA Study.
Espiritu AI; Chiu HHC; Sy MCC; Anlacan VMM; ; Jamora RDG
Sci Rep; 2021 Dec; 11(1):24436. PubMed ID: 34952903
[TBL] [Abstract][Full Text] [Related]
35. Whom Should We Test for COVID-19? Performance of a Symptom and Risk Factor Questionnaire on COVID-19 Test Results and Patient Outcomes in an Immediate Care Setting.
Oshman L; Caplan A; Ali R; Singh L; Khalid R; Jameel M; David SP
J Prim Care Community Health; 2020; 11():2150132720981297. PubMed ID: 33300408
[TBL] [Abstract][Full Text] [Related]
36. Not all COVID-19 pandemic waves are alike.
Domingo P; Pomar V; Mur I; Castellví I; Corominas H; de Benito N
Clin Microbiol Infect; 2021 Jul; 27(7):1040.e7-1040.e10. PubMed ID: 33887469
[TBL] [Abstract][Full Text] [Related]
37. Co-morbid conditions in COVID-19 patients in Uttarakhand state of India.
Goel D; Kumar S
J Glob Health; 2021 Feb; 11():03029. PubMed ID: 33692884
[No Abstract] [Full Text] [Related]
38. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
[TBL] [Abstract][Full Text] [Related]
39. Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients.
Semenzato L; Botton J; Drouin J; Baricault B; Vabre C; Cuenot F; Penso L; Herlemont P; Sbidian E; Weill A; Dray-Spira R; Zureik M
Hypertension; 2021 Mar; 77(3):833-842. PubMed ID: 33423528
[TBL] [Abstract][Full Text] [Related]
40. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
